title: Factor VIII inhibitors development following introduction of B-domain-deleted recombinant factor VIII in four hemophilia A previously treated patients.
authors: V
authors: V
authors: Roussel-Robert
authors: M F
authors: MF
authors: Torchet
authors: F
authors: F
authors: Legrand
authors: C
authors: C
authors: Rothschild
authors: N
authors: N
authors: Stieltjes
mesh_terms: D000328:Adult; D000368:Aged; D000917:Antibody Formation; D005169:Factor VIII / Q000276:immunology* / Q000627:therapeutic use; D006467:Hemophilia A / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007518:Isoantibodies / Q000097:blood; D008875:Middle Aged; D010446:Peptide Fragments / Q000276:immunology / Q000627:therapeutic use
chemical_list: C451034:B-domain-deleted factor VIII; D007518:Isoantibodies; D010446:Peptide Fragments; D005169:Factor VIII